Cash And Equivalent Cambio Fecha
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
Daiichi Sankyo JPY 590.77B 71.1B 2023-09
Gilead Sciences USD 8.43B 2.72B 2023-12
GlaxoSmithKline GBP 3.18B 37M 2023-09
Incyte USD 3.21B 13.85M 2023-12
Intra Cellular Therapies USD 147.77M 48.36M 2023-12
Ionis Pharmaceuticals USD 399.27M 47.21M 2023-12
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
PTC Therapeutics USD 594M 428.84M 2023-12
Regeneron Pharmaceuticals USD 16.24B 14.09B 2023-12
Roche Holding CHF 3.72B 1.27B 2023-06
Sarepta Therapeutics USD 541.93M 310M 2023-09
Ultragenyx Pharmaceutical USD 777.11M 704.54M 2023-12
Vertex Pharmaceuticals USD 11.11B 959.1M 2023-09



BioCryst Pharmaceuticals Efectivo Y Equivalentes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2024.